Journal
mBio
Publication Date
10-26-2021
Volume
12
Issue
5
First Page
e0239521
Document Type
Open Access Publication
DOI
10.1128/mBio.02395-21
Rights and Permissions
Su W, Sia SF, Schmitz AJ, Bricker TL, Starr TN, Greaney AJ, Turner JS, Mohammed BM, Liu Z, Choy KT, Darling TL, Joshi A, Cheng KM, Wong AYL, Harastani HH, Nicholls JM, Whelan SPJ, Bloom JD, Yen H-L, Ellebedy AH, Boon ACM. 2021. Neutralizing monoclonal antibodies that target the spike receptor binding domain confer Fc receptorindependent protection against SARS-CoV-2 infection in Syrian hamsters. mBio 12:e02395- 21. https://doi.org/10.1128/mBio.02395-21. © 2021 Su et al. This is an openaccess article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Recommended Citation
Su, Wen; Sia, Sin Fun; Schmitz, Aaron J; Bricker, Traci L; Starr, Tyler N; Greaney, Allison J; Turner, Jackson S; Mohammed, Bassem M; Liu, Zhuoming; Choy, Ka Tim; Darling, Tamarand L; Joshi, Astha; Cheng, Ka Man; Wong, Alvina Y L; Harastani, Houda H; Nicholls, John M; Whelan, Sean P J; Bloom, Jesse D; Yen, Hui-Ling; Ellebedy, Ali H; and Boon, Adrianus C M, "Neutralizing monoclonal antibodies that target the spike receptor binding domain confer Fc receptor-independent protection against SARS-CoV-2 infection in Syrian hamsters." mBio. 12, 5. e0239521 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11446
Supplemental Figure 1
mbio.02395-21-sf002.tif (1264 kB)
Supplemental Figure 2
mbio.02395-21-sf003.tif (237 kB)
Supplemental Figure 3
